tiprankstipranks
Migdal Insurance & Financial Holdings Ltd. (IL:MGDL)
TASE:MGDL
Israel Market
Want to see IL:MGDL full AI Analyst Report?

Migdal Insur. (MGDL) AI Stock Analysis

6 Followers

Top Page

IL:MGDL

Migdal Insur.

(TASE:MGDL)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - Gpt-5.6Sol)
Rating:66Neutral
Price Target:
1,938.00
▲(9.80% Upside)
Action:Downgraded
Date:08/19/26
The score is primarily driven by improved profitability and strong ROE, tempered by major revenue volatility and a notable TTM free-cash-flow deterioration. Technicals are mildly constructive but not strong enough to offset the cash-flow setback, while the low P/E provides valuation support.
Positive Factors
Improved Profitability
The sharp improvement in net income and EBIT margin indicates stronger operating economics than in prior years. If sustained, this creates a better earnings base across Migdal’s insurance and financial-services operations.
Negative Factors
Revenue Volatility
Severe top-line volatility makes it harder to assess the durability of recent profit gains. It may reflect investment-related or insurance-accounting movements, but it still complicates planning and reduces confidence in recurring revenue progression.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Profitability
The sharp improvement in net income and EBIT margin indicates stronger operating economics than in prior years. If sustained, this creates a better earnings base across Migdal’s insurance and financial-services operations.
Read all positive factors

Migdal Insur. (MGDL) vs. iShares MSCI Israel ETF (EIS)

Migdal Insur. Business Overview & Revenue Model

Company Description
Migdal Insurance and Financial Holdings Ltd., along with its various subsidiaries, offers a comprehensive suite of insurance, pension, and financial solutions to both individual and institutional clients across Israel. The firm's extensive offerin...
How the Company Makes Money
Migdal primarily makes money through (1) underwriting income and policy-related fees from its insurance operations and (2) investment and asset-management related income from managing insurance and long-term savings assets. 1) Insurance underwrit...

Migdal Insur. Financial Statement Overview

Summary
Earnings and margins improved sharply versus prior years (net income up to ~1.83B in 2025 and ~1.90B TTM; EBIT margin ~8.9% vs ~3.7% in 2024) and ROE is strong (~18–20%). Offsetting this, revenue is highly volatile with a steep TTM decline, and the latest TTM cash-flow quality weakened materially (negative free cash flow), raising durability and near-term quality-of-earnings risk.
Income Statement
72
Positive
Balance Sheet
70
Positive
Cash Flow
55
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue35.86B34.70B33.74B28.47B6.44B36.68B
Gross Profit34.04B34.70B32.38B28.47B6.44B36.68B
EBITDA3.60B3.40B1.47B1.28B1.51B2.49B
Net Income1.90B1.83B608.16M587.18M750.97M1.39B
Balance Sheet
Total Assets256.34B246.30B219.64B204.86B196.90B204.16B
Cash, Cash Equivalents and Short-Term Investments2.35B3.52B46.09B41.00B38.79B37.79B
Total Debt8.34B8.24B5.99B5.97B7.19B5.42B
Total Liabilities245.48B236.34B210.09B196.26B188.80B195.59B
Stockholders Equity10.85B9.95B9.54B8.59B8.09B8.56B
Cash Flow
Free Cash Flow-1.65B5.52B3.05B2.15B-3.11B6.88B
Operating Cash Flow2.71B5.60B3.38B2.44B-2.85B7.12B
Investing Cash Flow-473.00M-405.00M-353.88M-284.03M-254.66M-245.25M
Financing Cash Flow569.00M645.00M630.00M-1.35B1.18B773.24M

Migdal Insur. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
₪28.59B11.703.29%43.27%99.24%
71
Outperform
₪3.45B9.437.08%9.90%22.54%
66
Neutral
₪18.62B9.762.14%116.73%
66
Neutral
₪43.19B12.823.14%28.82%58.47%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:MGDL
Migdal Insur.
1,794.00
728.00
68.29%
IL:PHOE
Phoenix
17,210.00
6,076.05
54.57%
IL:MMHD
Menora Miv Hld
46,570.00
16,774.09
56.30%
IL:ZUR
Zur
1,258.00
291.36
30.14%
IL:IDIN
Idi Insur
23,090.00
4,590.48
24.81%
IL:IBIU
Ibi Underwrit
1,130.00
280.94
33.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2026